Natural killer cell cytokine response to M. bovis BCG Is associated with inhibited proliferation, increased apoptosis and ultimate depletion of NKp44(+)CD56(bright) cells.
Mycobacterium bovis BCG, a live attenuated strain of M. bovis initially developed as a vaccine against tuberculosis, is also used as an adjuvant for immunotherapy of cancers and for treatment of parasitic infections. The underlying mechanisms are thought to rely on its immunomodulatory properties in...
Saved in:
| Main Authors: | Damien Portevin, Douglas Young |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0068864&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hypercytotoxicity and rapid loss of NKp44+ innate lymphoid cells during acute SIV infection.
by: Haiying Li, et al.
Published: (2014-12-01) -
Targeting natural killer cell reactivity by employing antibody to NKp46: implications for type 1 diabetes.
by: Rami Yossef, et al.
Published: (2015-01-01) -
Single-cell profiling aligns CD56bright and cytomegalovirus-induced adaptive natural killer cells to a naïve-memory relationship
by: M. Kazim Panjwani, et al.
Published: (2024-12-01) -
Impact of antibody architecture and paratope valency on effector functions of bispecific NKp30 x EGFR natural killer cell engagers
by: Ammelie Svea Boje, et al.
Published: (2024-12-01) -
Dendritic Cell Activity Driven by Recombinant Mycobacterium bovis BCG Producing Human IL-18, in Healthy BCG Vaccinated Adults
by: Piotr Szpakowski, et al.
Published: (2015-01-01)